Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia

被引:0
|
作者
Megan N. Willson
Joshua J. Neumiller
David A. Sclar
Linda M. Robison
Tracy L. Skaer
机构
[1] Washington State University,Department of Pharmacotherapy, College of Pharmacy
[2] Washington State University,Department of Health Policy and Administration, College of Pharmacy
关键词
Cholesterol; Equitable Access; High Total Cholesterol; National Ambulatory Medical Care Survey; Cholesterol Screening;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:105 / 108
页数:3
相关论文
共 4 条
  • [1] Ethnicity/Race, Use of Pharmacotherapy, Scope of Physician-Ordered Cholesterol Screening, and Provision of Diet/Nutrition or Exercise Counseling during US Office-Based Visits by Patients with Hyperlipidemia
    Willson, Megan N.
    Neumiller, Joshua J.
    Sclar, David A.
    Robison, Linda M.
    Skaer, Tracy L.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (02) : 105 - 108
  • [2] Ethnicity/Race and the Extent of Physician-Ordered Hemoglobin A1C During US Office-Based Visits by Patients With Diabetes Mellitus
    Neumiller, Joshua J.
    Sclar, David A.
    Robison, Linda M.
    Maldonado, Angela L.
    Setter, Stephen M.
    Skaer, Tracy L.
    [J]. DIABETES EDUCATOR, 2010, 36 (01): : 65 - 66
  • [3] Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits
    Jackowski, Rebekah M.
    Pogge, Elizabeth K.
    Early, Nicole K.
    Fairman, Kathleen A.
    Sclar, David A.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (01) : 65 - 71
  • [4] Provision of Lifestyle Counseling and the Prescribing of Pharmacotherapy for Hyperlipidemia Among US Ambulatory Patients: A National Assessment of Office-Based Physician Visits
    Rebekah M. Jackowski
    Elizabeth K. Pogge
    Nicole K. Early
    Kathleen A. Fairman
    David A. Sclar
    [J]. American Journal of Cardiovascular Drugs, 2018, 18 : 65 - 71